The Patent Finder

Mirna Therapeutics, Inc.

Also on record
Records under this name other than patents Mirna Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Mirna Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,611,478Synthetic mimics of miR-124
Lapsed on the fee record
Ended Apr 4, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 4, 2021USPTO record
US 9,540,645Compositions and Methods Related to Mirna Modulation of Neovascularization or Angiogenesis
Lapsed on the fee record
Ended Jan 10, 2021 · High confidence
Lapsed on the fee recordEnded Jan 10, 2021High confidence
US 9,517,245Sorafenib-microRNA combination therapy for liver cancer
Lapsed on the fee record
Ended Dec 13, 2020 · USPTO record
Lapsed on the fee recordEnded Dec 13, 2020USPTO record
US 8,258,111Compositions and Methods Related to Mirna Modulation of Neovascularization or Angiogenesis
Lapsed on the fee record
Ended Sep 4, 2020 · High confidence
Lapsed on the fee recordEnded Sep 4, 2020High confidence
US 9,371,526Synthetic mimics of miR-34
Lapsed on the fee record
Ended Jun 21, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 21, 2020USPTO record
US 9,365,852Compositions and Methods Related to Mirna Modulation of Neovascularization or Angiogenesis
Lapsed on the fee record
Ended Jun 14, 2020 · High confidence
Lapsed on the fee recordEnded Jun 14, 2020High confidence
US 9,222,085Synthetic mimics of MIR-124
Lapsed on the fee record
Ended Dec 29, 2019 · USPTO record
Lapsed on the fee recordEnded Dec 29, 2019USPTO record
US 8,071,562MIR-124 Regulated Genes and Pathways as Targets for Therapeutic Intervention
Lapsed on the fee record
Ended Dec 6, 2019 · High confidence
Lapsed on the fee recordEnded Dec 6, 2019High confidence
US 8,900,627Novel Compositions for the in Vivo Delivery of Rnai Agents
Formerly held
Lapsed on the fee record
Ended Dec 2, 2018 · High confidence
Lapsed on the fee recordEnded Dec 2, 2018High confidence
US 8,586,727Synthetic mimics of miR-34
Lapsed on the fee record
Ended Nov 19, 2017 · USPTO record
Lapsed on the fee recordEnded Nov 19, 2017USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited